Lyman, G. H., Eckert, L., Wang, Y., Wang, H. & Cohen, A. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist 18, 1321–1329 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Lyman, G. H., Culakova, E., Poniewierski, M. S. & Kuderer, N. M. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb. Res. 164, S112–S118 (2018).

Article  CAS  PubMed  Google Scholar 

Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M. & Lyman, G. H. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J. Thromb. Haemost. 5, 632–634 (2007).

Article  CAS  PubMed  Google Scholar 

Agnelli, G. et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N. Engl. J. Med. 366, 601–609 (2012).

Article  CAS  PubMed  Google Scholar 

Agnelli, G. et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol. 10, 943–949 (2009).

Article  CAS  PubMed  Google Scholar 

Carrier, M. et al. Apixaban to prevent venous thromboembolism in patients with cancer. N. Engl. J. Med. 380, 711–719 (2018).

Article  PubMed  Google Scholar 

Khorana, A. A. et al. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N. Engl. J. Med. 380, 720–728 (2019).

Article  CAS  PubMed  Google Scholar 

Li, A. et al. Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States. Cancer 126, 1736–1748 (2020).

Article  PubMed  Google Scholar 

Lyman, G. H. et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 5, 927–974 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Key, N. S. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J. Clin. Oncol. 38, 496–520 (2019).

Article  PubMed  Google Scholar 

Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H. & Francis, C. W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111, 4902–4907 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuderer, N. M. et al. Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK). Oncologist 23, 247–255 (2018).

Article  PubMed  Google Scholar 

Mansfield, A. S. et al. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. J. Thromb. Haemost. 14, 1773–1778 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mulder, F. I. et al. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 104, 1277 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Li, A. et al. Derivation and validation of a clinical risk assessment model for cancer-associated thrombosis in two unique US health care systems. J. Clin. Oncol. 41, 2926–2938 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pabinger, I. et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 5, e289–e298 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Connors, J. M. Fine tuning venous thromboembolism risk prediction in patients with cancer. J. Clin. Oncol. 41, 2881–2883 (2023).

Article  CAS  PubMed  Google Scholar 

Holmes, C. E. et al. Successful model for guideline implementation to prevent cancer-associated thrombosis: venous thromboembolism prevention in the ambulatory cancer clinic. JCO Oncol. Pract. 16, e868–e874 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Khorana, A. A. Simplicity versus complexity: an existential dilemma as risk tools evolve. Lancet Haematol. 5, e273–e274 (2018).

Article  PubMed  Google Scholar 

Blom, J. W., Doggen, C. J. M., Osanto, S. & Rosendaal, F. R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293, 715–722 (2005).

Article  CAS  PubMed  Google Scholar 

Muñoz, A. et al. A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts. J. Clin. Oncol. 41, 2911–2925 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Zwicker, J. I. et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin. Cancer Res. 15, 6830–6840 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khorana, A. A. et al. A proteomics-based approach to identifying mechanisms of cancer-associated thrombosis: potential role for immunoglobulins. Blood 122, 1127 (2013).

Article  Google Scholar 

FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers. US FDA www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-liquid-biopsy-ngs-companion-diagnostic-test-multiple-cancers-and-biomarkers (2020).

Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. USA 107, 15880–15885 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauracher, L.-M. et al. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients. J. Thromb. Haemost. 16, 508–518 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Jee, J. et al. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. Nat. Med. 28, 2353–2363 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vivancos, A. & Tabernero, J. Circulating tumor DNA as a novel prognostic indicator. Nat. Med. 28, 2255–2256 (2022).

Article  CAS  PubMed  Google Scholar 

Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616, 553–562 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Syeda, M. M. et al. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. Lancet Oncol. 22, 370–380 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reichert, Z. R. et al. Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study. Ann. Oncol. 34, 111–120 (2023).

Article  CAS  PubMed